High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
Crypto investigator ZachXBT redirected about $41,000 in unsolicited meme-coin inflows into earthquake relief for Vene...
This article dives into why this dividend stock's moat offers unparalleled stability for long-term investors. Discove...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Thailand confronts a high-stakes case that blends illegal crypto mining with money laundering. This article breaks do...
A new leadership style at the Fed could change how markets price future rate moves. This article breaks down the pote...
Could a modest $5,000 investment unlock meaningful dividend income? This guide breaks down the math, the role of high...
Rising AI chip costs and surging demand threaten to reshape consumer budgets, credit behavior, and retirement plannin...
A major box-office milestone puts spotlight on how music biopics monetize beyond ticket sales. Learn practical, money...
Energy markets offer unique opportunities and risks. This expert guide breaks down actionable investment strategies i...
Investors often ask if selling Tesla to invest in SpaceX could pay off. This guide breaks down the reality, the optio...